Influence of interleukin 17 A and 17 F polymorphisms in keratoconus

Mol Biol Rep. 2021 Nov;48(11):7165-7170. doi: 10.1007/s11033-021-06708-z. Epub 2021 Sep 23.

Abstract

Background: Until a few years ago, keratoconus was defined as a noninflammatory degenerative disease. However, recent studies have shown that the altered balance between inflammatory cytokines, proteases, and protease inhibitors, as well as free radicals and oxidants, have a crucial role in the pathogenesis of this disease. The aim of this study is to investigate whether interleukin 17 A G197A (rs2275913) and interleukin 17 F T7488C (rs763780) polymorphisms are associated with keratoconus in patients from a population of the northwestern region of the State of São Paulo, Brazil.

Methods and results: 35 patients and 61 controls were enrolled. Genotyping of interleukin 17 A G197A and interleukin 17 F T7488C polymorphisms was carried out using the polymerase chain reaction-restriction fragment length polymorphism technique. Statistical analyses were conducted using the chi-square test, and an odds ratio with a 95% confidence interval was also calculated to evaluate the association between polymorphisms and disease. Evaluating interleukin 17 F T7488C, we found that the TT genotype is associated as a risk factor for keratoconus (P = 0.04; OR = 3.01; CI 1.11-8.14). As for evaluating interleukin 17 A G197A, the allele and genotype frequencies between patients and controls were compared and no statistically significant differences were found.

Conclusions: Our data showed that the interleukin 17 F T7488C polymorphisms may exert an influence in keratoconus.

Keywords: Cytokines; Ectasia; Genetic polymorphisms; IL17 genotypes; Interleukins; Keratoconus.

Publication types

  • Clinical Trial

MeSH terms

  • Adolescent
  • Adult
  • Female
  • Genotype*
  • Humans
  • Interleukin-17 / genetics*
  • Keratoconus / genetics*
  • Male
  • Polymorphism, Restriction Fragment Length*
  • Risk Factors

Substances

  • IL17A protein, human
  • IL17F protein, human
  • Interleukin-17